Baseline characteristics of participants. by Hyungjong Park (10147327)

“…Dyslipidemia was characterized by meeting the following criteria: having at least one claim of International Classification of Diseases (ICD)-10 code (E78) with an anti-dyslipidemia agent prescription, claims of ICD-10 code (E78) occurring more than twice, a total cholesterol level ≥ 240 mg/dL, low-density lipoprotein cholesterol ≥ 160 mg/dL, triglycerides ≥ 200 mg/dL, or high-density lipoprotein cholesterol < 40 mg/dL. …”

The rotenone-mediated oxidative stress is partially alleviated in EthMP treated mice. by Rabia Anjum (18388446)

Effect of polymer composition. by Yi Bao (278186)

Immunofluorescence staining of oxidative stress mediators in retinas. by Po-Ting Yeh (845796)

Image_1_Different Renal Function Patterns in Patients With Acute Heart Failure: Relationship With Outcome and Congestion.jpeg by Alberto Palazzuoli (12203753)

Image_2_Different Renal Function Patterns in Patients With Acute Heart Failure: Relationship With Outcome and Congestion.jpeg by Alberto Palazzuoli (12203753)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial by Xavier Duval (134550)

“…Mean day 0 to day 2 viral load decrease was 2.14, 2.49, and 1.68 log₁₀ cgeq/µl (<em>p</em> = 0.060, <em>p</em> = 0.016 for OZ/O and OZ/Z). …”

CyclinD1 transcriptional repression by T3 implicates thyroid hormone receptor α1 (TRα1) by Zahra Hassani (31174)

“…T3 treatment induces a strong decrease in cyclinD1-luciferase expression compared to the control group. () Different doses (ranging from 2 to 200 nM) of siRNAs directed against TRα1 (siTRα1) were co-injected along with the CyclinD1-luciferase plasmid in the lateral ventricles of euthyroid newborn mice, inducing a strong activation of CyclinD1-luciferase expression. () The same experiment as described in (c) was performed by using plasmids coding for shTRα1 instead of siTRα1. …”

Supplementary Material for: Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma by Siegel A.B. (4148563)

“…The maximum tolerated dose of sorafenib was 200 mg BID. Grade 3-4 toxicities seen in >10% of subjects included leukopenia (21%), elevated gamma-glutamyl transferase (21%), hypertension (14%), hand-foot syndrome (14%) and diarrhea (14%). …”

The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

Data_Sheet_2_Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.pdf by Richard J. Nowak (304244)

Data_Sheet_1_Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study.pdf by Richard J. Nowak (304244)

Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats by Shibin Ding (288560)

DataSheet_2_Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial.docx by Liudan Tu (8846261)

“…Adult AS patients with BASDAI ≥4 or ASDAS ≥2.1, CRP >6 mg/L, or ESR 28 mm/1st hour were randomly assigned (1:1:1 ratio) to celecoxib 200 mg bid or etanercept 50 mg qw or combined therapy for 52 weeks. …”

DataSheet_1_Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial.docx by Liudan Tu (8846261)

“…Adult AS patients with BASDAI ≥4 or ASDAS ≥2.1, CRP >6 mg/L, or ESR 28 mm/1st hour were randomly assigned (1:1:1 ratio) to celecoxib 200 mg bid or etanercept 50 mg qw or combined therapy for 52 weeks. …”

<b>Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Cli... by Ellen M. Apperloo (20405468)

“…</p><p dir="ltr"><i>Results:</i> The adjusted (95% CI) mean percent change from baseline in UACR for tirzepatide 5, 10, or 15 mg compared with all pooled comparators was -19.3% (-25.5, -12.5), -22.0% (-28.1, -15.3) and -26.3 (-32.0, -20.0), respectively, at Week 40/42. …”

Increased synaptosomal Nox-2 activation and superoxide production in old wild-type mice is absent in old IL-6-/- mice; determination by electrochemical oxygen consumption analysis... by Laura L. Dugan (264427)

“…(b) Representative EPR spectra recorded 3 minutes after mixing 5 mM NADPH with 0.2–0.5 mg synaptosomal protein isolated from brain of old mice at 37°C with 70 mM DEPMPO in the absence or in the presence of 200 µM AEBSF or 300 µM apocynin. …”

DataSheet_1_Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example.docx by Lina Keutzer (8895404)

Effect of Omega-3 Fatty Acid Ethyl Esters on the Oxylipin Composition of Lipoproteins in Hypertriglyceridemic, Statin-Treated Subjects by John W. Newman (121459)